Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-33 as a novel diagnostic biomarker for distinguishing cholesterol from adenomatous polyps: a case-control study. | Hereditas | 2025 | 40087680 | PubTator, text mining | PubMed |
| Intramolecular DNA Wheel Construction for Highly Sensitive Electrochemical Detection of miRNA. | Nano Lett | 2025 | 39814677 | PubTator, text mining | PubMed |
| MicroRNA-199a-5p may be a diagnostic biomarker of primary ITP. | Br J Haematol | 2025 | 39776057 | PubTator, text mining | PubMed |
| MicroRNA-33 regulates the synaptic plasticity-related gene ARC in temporal lobe epilepsy. | Neurosci Res | 2025 | 39214315 | PubTator, text mining | PubMed |
Effects of multi-species synbiotic supplementation on circulating miR-27a, miR-33a levels and lipid parameters in adult men with dyslipidaemia; a randomised, double-blind, placebo-controlled clinical trial. | Br J Nutr | 2025 | 38684660 | PubTator, text mining | PubMed |
| miRNA in mechanobiology: The exploration needs to continue. | Mechanobiol Med | 2024 | 40395226 | PubTator, text mining | PubMed |
| MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study. | Noncoding RNA | 2024 | 39311383 | PubTator, text mining | PubMed |
| Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells. | AAPS PharmSciTech | 2024 | 39266895 | PubTator, text mining | PubMed |
| miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression. | JCI Insight | 2024 | 39190492 | PubTator, text mining | PubMed |
| miRNA and leptin signaling in metabolic diseases and at extreme environments. | Pharmacol Res Perspect | 2024 | 39017237 | PubTator, text mining | PubMed |
| Resveratrol suppresses hepatic fatty acid synthesis and increases fatty acid β-oxidation via the microRNA-33/SIRT6 signaling pathway. | Exp Ther Med | 2024 | 38979023 | PubTator, text mining | PubMed |
| LncRNA DANCR promotes macrophage lipid accumulation through modulation of membrane cholesterol transporters. | Aging (Albany NY) | 2024 | 38968577 | PubTator, text mining | PubMed |
| MiR-33a Overexpression Exacerbates Diabetic Nephropathy Through Sirt6-dependent Notch Signaling. | Iran J Kidney Dis | 2024 | 38904337 | PubTator, text mining | PubMed |
| Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review. | Open Biol | 2024 | 38889771 | PubTator, text mining | PubMed |
| A novel TGFbeta/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression. | Cell Death Dis | 2024 | 38806480 | PubTator, text mining | PubMed |
| Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis. | Int J Exp Pathol | 2024 | 38722178 | PubTator, text mining | PubMed |
| Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure. | Heliyon | 2024 | 38601677 | PubTator, text mining | PubMed |
| Time for micro-RNAs in steatotic liver disease: a case-control study. | Front Endocrinol (Lausanne) | 2024 | 38549763 | PubTator, text mining | PubMed |
| Characterization of exosomal microRNAs in preterm infants fed with breast milk and infant formula. | Front Nutr | 2024 | 38304545 | PubTator, text mining | PubMed |
| Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. | Genes Dis | 2024 | 38292177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=3